Announcements Trials
Browse Landscape

Status

Completed 3

Sponsor Class

INDUSTRY 2OTHER_GOV 1

Study Type

Observational 3

Sponsor

Cancer Type

Gastrointestinal 3Thoracic 1Sarcoma 1Genitourinary 1

Conditions

Neoplasms 5Colorectal Neoplasms, Hereditary Nonpolyposis 3Colorectal Neoplasms 3Sarcoma 2Recurrence 2Carcinoma, Non-Small-Cell Lung 2Breast Neoplasms 2Stage IIIb and IV Non Small Cell Lung Cancer 1Solid Tumor, Adult 1Rare Diseases 1Prostatic Neoplasms 1Ovarian Neoplasms 1Neuroblastoma 1Neoplastic Syndromes, Hereditary 1Neoplasm, Residual 1Neoplasm Metastasis 1Multiple Myeloma 1Mouth Neoplasms 1Microsatellite Instability 1Lymphoma, Non-Hodgkin 1Lung Neoplasms 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Hereditary Breast and Ovarian Cancer Syndrome 1Head and Neck Neoplasms 1Genetic Predisposition to Disease 1Colonic Neoplasms 1Carcinoma, Transitional Cell 1Carcinoma, Medullary 1COVID-19 1Biliary Tract Neoplasms 1

Interventions

Fluorouracil 498Bevacizumab 476Oxaliplatin 450Leucovorin 442Irinotecan 408Cetuximab 318Capecitabine 317pembrolizumab 142Folfox protocol 128Panitumumab 117regorafenib 105Colonoscopy 88Nivolumab 82IFL protocol 81Drug Therapy 77trifluridine tipiracil drug combination 73Radiotherapy 66HMPL-013 65Blood Specimen Collection 52Gemcitabine 49Specimen Handling 47Standard of Care 45Neoadjuvant Therapy 45Magnetic Resonance Spectroscopy 44Biopsy 44Chemotherapy, Adjuvant 41Trifluridine 40atezolizumab 39Cyclophosphamide 39Surveys and Questionnaires 38

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Colorectal Neoplasms × High-Throughput Nucleotide Sequencing × Clear all
NCT03546127 2025-09-11

MULTIPLI-0

Institut National de la Santé Et de la Recherche Médicale, France

Completed
24 enrolled
GastrointestinalSarcoma

Sarcoma, Colorectal Neoplasms

NCT05158621 2022-10-18

A Screening Study Targeting Tumor-specific Antigens

Gritstone bio, Inc.

Completed
22 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT03794128 2020-09-11

A Study of Personalized Neoantigen Cancer Vaccines

Gritstone bio, Inc.

Completed
93 enrolled
GastrointestinalGenitourinaryThoracic

Carcinoma, Non-Small-Cell Lung, Carcinoma, Transitional Cell, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡